Genetic Engineering and Biotechnology News

Aims & Scope

Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc.

Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities.

With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.

Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success.

GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.140

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	12

Journal Rank

Year	Value
2024	25333

Journal Citation Indicator

Year	Value
2024	33

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Business, Management and Accounting, Chemical Engineering and Engineering, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Bridging Genomics and Tissue Pathology

  Citation: 66

  Authors: Nikhil, Sheila, Olivia

• Gene Therapy: It Is Time to Talk about High-Dose AAV

  Citation: 35

  Authors: Nicole

• Continuous Production of Exosomes

  Citation: 30

  Authors: William, John W., John J.S.

• The Move toward Biopharma 4.0

  Citation: 27

  Authors: Shilpa, Kathrin, Klaus

• Efficient Production of rAAV in a Perfusion Bioreactor Using an ELEVECTA^® Stable Producer Cell Line

  Citation: 14

  Authors: Juliana, Aishwarya, Ahmad, Thomas, Nicole, Silke

• Single-Cell Multiomics: Simultaneous Epigenetic and Transcriptional Profiling

  Citation: 14

  Authors: Kamila, Laura, Olivia

• Top 15 Best-Selling Drugs of 2018

  Citation: 13

  Authors: Alex

• COVID-19: Top 60 Drug Treatments in Development

  Citation: 13

  Authors: Alex

• Plant-Based Protein Biomanufacturing

  Citation: 12

  Authors: Amanda, Ning, Greg

• Bioprinting: From Patches to Parts

  Citation: 12

  Authors: Ken

---